Author

E. Ellsworth

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:metagenomics· 1 Approach:statistical model· 1

Frequent Co-Authors

R. B. Abramovitch· 2 shared B. Aleiwi· 1 shared C. Chen· 1 shared E. R. Haiderer· 1 shared G. B. Coulson· 1 shared H. Zheng· 1 shared J. T. Williams· 1 shared K. N. Conner· 1 shared

Activity by Year

2018-2019 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

R. B. Abramovitch

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Identification of new MmpL3 inhibitors by untargeted and targeted mutant screens defines MmpL3 domains with differential resistance

J. T. Williams, E. R. Haiderer, G. B. Coulson, K. N. Conner, E. Ellsworth, C. Chen, T. Dick, R. B. Abramovitch

The paper identifies new MmpL3 inhibitors through screens and analyzes resistance mutations to define clades of inhibitors and mutants with differential resistance.

bioRxiv · Feb 28, 2019Microbiology

Inhibition of Mycobacterium tuberculosis DosRST two-component regulatory system signaling by targeting response regulator DNA binding and sensor kinase heme

H. Zheng, B. Aleiwi, E. Ellsworth, R. B. Abramovitch

This study identifies two inhibitors of the Mtb DosRST regulatory system, showing they target different components of the pathway and reduce hypoxia-induced persistence.

bioRxiv · Sep 11, 2018Microbiology